ArticleIn vivo (Athens, Greece)

Evaluation of Lung Adverse Events Associated With Lenvatinib: A Post-marketing Surveillance Study.

Yuko Kanbayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.